135 related articles for article (PubMed ID: 36705380)
21. Biphasic low-grade nasopharyngeal papillary adenocarcinoma: a case report and literature review.
Yokoi H; Terado Y; Fujiwara M; Matsumoto Y; Ikeda T; Saito K
BMC Clin Pathol; 2018; 18():10. PubMed ID: 30323715
[TBL] [Abstract][Full Text] [Related]
22. Thyroid-like papillary adenocarcinoma of the nasopharynx: a case report in a 19-year-old male.
Sillings CN; Weathers DR; Delgaudio JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep; 110(3):e25-8. PubMed ID: 20727493
[TBL] [Abstract][Full Text] [Related]
23. Radiological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case series and systematic review.
Baba A; Matsushima S; Kessoku H; Omura K; Kurokawa R; Fukasawa N; Takeshita Y; Yamauchi H; Ogino N; Kayama R; Uchihara K; Yoshimatsu L; Ojiri H
Neuroradiology; 2024 Feb; 66(2):249-259. PubMed ID: 38103083
[TBL] [Abstract][Full Text] [Related]
24. Nasopharyngeal adenocarcinomas: a clinicopathologic study of 44 cases including immunohistochemical features of 18 papillary phenotypes.
Pineda-Daboin K; Neto A; Ochoa-Perez V; Luna MA
Ann Diagn Pathol; 2006 Aug; 10(4):215-21. PubMed ID: 16844563
[TBL] [Abstract][Full Text] [Related]
25. The rare combination of low-grade thyroid-like nasopharyngeal papillary adenocarcinoma and squamous cell carcinoma: a case report and literature review.
Toyran T; Inceman M; Erdogan K; Kücükosmanoglu A; Ekici NY; Ugu AH
Pol J Pathol; 2022; 73(4):359-363. PubMed ID: 36946273
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Features of Low-Grade Thyroid-like Nasopharyngeal Papillary Adenocarcinoma.
Li M; Wei J; Yao X; Wang C
Cancer Res Treat; 2017 Jan; 49(1):213-218. PubMed ID: 27384157
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
Abouhashem NS; Talaat SM
Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
[TBL] [Abstract][Full Text] [Related]
28. Biphasic Thyroid-Like Low-Grade Nasopharyngeal Papillary Adenocarcinoma with a Prominent Spindle Cell Component: A Case Report.
Lee SH; Kim H; Kim MJ; Kim B; Kim HS
Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32438756
[TBL] [Abstract][Full Text] [Related]
29. Low-grade papillary adenocarcinoma of nasopharynx with expression of thyroid transcription factor-1: Case report and review of literature.
Rajeswari B; Sukumaran Nair RK; Parukuttyamma K; Mathews A
Indian J Pathol Microbiol; 2016; 59(4):518-520. PubMed ID: 27721286
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.
Song Q; Wang D; Lou Y; Li C; Fang C; He X; Li J
Diagn Pathol; 2011 Dec; 6():126. PubMed ID: 22188859
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
Murtezaoglu AR; Gucer H
Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma.
Chen W; Zhao J
Asian J Surg; 2024 May; 47(5):2433-2434. PubMed ID: 38302361
[No Abstract] [Full Text] [Related]
33. [A thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
Colombé C; Gil H; Righini CA
Ann Pathol; 2021 Jun; 41(3):323-325. PubMed ID: 33494952
[TBL] [Abstract][Full Text] [Related]
34. Expression of cytokeratin-19 (CK19) in the classical subtype of papillary thyroid carcinoma: the experience of one center in the Silesian region.
Kaliszewski K; Diakowska D; Strutynska-Karpinska M; Rzeszutko M; Grzegrzolka J; Dziegiel P; Wojtczak B; Sutkowski K
Folia Histochem Cytobiol; 2016; 54(4):193-201. PubMed ID: 28051274
[TBL] [Abstract][Full Text] [Related]
35. Low-Grade Nasopharyngeal Papillary Adenocarcinoma.
Wang L; Min Q; Jiang J; Shao Y; Cao Y; Yan D
J Coll Physicians Surg Pak; 2019 Nov; 29(11):1114-1115. PubMed ID: 31659975
[TBL] [Abstract][Full Text] [Related]
36. Exclusive Endoscopic Resection of Nasopharyngeal Papillary Adenocarcinoma via Combined Transnasal and Transoral Approach.
Ryu J; Park WS; Jung YS
Clin Exp Otorhinolaryngol; 2013 Mar; 6(1):48-51. PubMed ID: 23526700
[TBL] [Abstract][Full Text] [Related]
37. Primary thyroid-like papillary adenocarcinoma of the nasopharynx.
Fu CH; Chang KP; Ueng SH; Wu CC; Hao SP
Auris Nasus Larynx; 2008 Dec; 35(4):579-82. PubMed ID: 18201851
[TBL] [Abstract][Full Text] [Related]
38. Nasopharyngeal thyroid-like low-grade papillary adenocarcinoma.
Borsetto D; Cazzador D; Prosenikliev V; Zamon A; Volo T; Marino F; Emanuelli E
B-ENT; 2016; 12(3):235-240. PubMed ID: 29727129
[TBL] [Abstract][Full Text] [Related]
39. Identification of metastatic papillary thyroid carcinoma in FNA specimens using thyroid peroxidase immunohistochemistry.
Shield PW; Crouch SJ; Papadimos DJ; Walsh MD
Cytopathology; 2018 Jun; 29(3):227-232. PubMed ID: 29508480
[TBL] [Abstract][Full Text] [Related]
40. Nasopharyngeal Papillary Adenocarcinoma as a Second Head and Neck Malignancy.
Kakkar A; Sakthivel P; Mahajan S; Thakar A
Head Neck Pathol; 2019 Dec; 13(4):699-704. PubMed ID: 29923095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]